Literature DB >> 11108215

Improved orthopaedic bone cement formulations based on rubber toughening.

A D Puckett1, B Roberts, L Bu, J W Mays.   

Abstract

Poly(methylmethacrylate) (PMMA) bone cements have been used for the fixation of hip and knee implants since the early 1960s. Aseptic loosening, related to fracture of the PMMA, continues to be the primary mode of failure for these prostheses. Failed prostheses must be replaced causing additional expense and patient trauma. Furthermore, the average lifetime of the revised prosthesis is significantly lower than that of a primary prosthesis. Recent work by Moseley and co-workers led to the development of a promising new rubber toughened cement. It is comprised of a matrix of the traditional PMMA with dispersed rubber particles to modify mechanical properties and, in particular, improve fracture toughness. The fracture toughness of the experimental material was 167% greater than the toughness of a nontoughened control; however, the elastic modulus and compressive strength were reduced. The reductions in properties should not pose a clinical problem based on results of the implant model reported by Moseley. More serious concerns were mixing and delivery problems and high residual monomer concentrations. The formulation and chemical/mechanical characterization of new toughened acrylic formulations that have residual monomer levels equivalent to Simplex and better mixing properties are reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108215     DOI: 10.1615/critrevbiomedeng.v28.i34.180

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  2 in total

1.  Polymethylmethacrylate bone cements and additives: A review of the literature.

Authors:  Manit Arora; Edward Ks Chan; Sunil Gupta; Ashish D Diwan
Journal:  World J Orthop       Date:  2013-04-18

2.  A novel liposomal drug delivery system for PMMA bone cements.

Authors:  Wayne Nishio Ayre; James C Birchall; Samuel L Evans; Stephen P Denyer
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-08-10       Impact factor: 3.368

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.